Radius Health, 3% 1sep2024, USD (Conv.) (FIGI BBG00HDQJN54, WKN A19M13)
国内債券, 転換社債, トレース適格, Senior Unsecured
国内債券, 転換社債, トレース適格, Senior Unsecured
|
Radius Health, Inc., a biopharmaceutical company, develops and sells therapeutics in the areas of osteoporosis, oncology, and endocrine diseases primarily in the United States. Its product candidates include Abaloparatide-SC, an injectable subcutaneous formulation of abaloparatide, which ...
Radius Health, Inc., a biopharmaceutical company, develops and sells therapeutics in the areas of osteoporosis, oncology, and endocrine diseases primarily in the United States. Its product candidates include Abaloparatide-SC, an injectable subcutaneous formulation of abaloparatide, which has completed Phase III clinical trial for the treatment of patients with postmenopausal osteoporosis; and Abaloparatide-TD, a transdermal patch for use as a short wear-time transdermal patch. Radius Health, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
100 000
株
175 910
ETF&投資信託
100 000
インデックス
最も効率的な方法でポートフォリオを追跡